Bank of America cuts Abivax stake to 4.96%
Bank of America cut its stake in Abivax to 4.96% on Sept. 9, holding 4,323,717 shares, with voting rights exposure dropping to 4.88%. The move followed market sales, partly offset by positions equivalent to share ownership.